compounding your own semaglutide Pharma's mess of its making — greed, secrecy and weight-loss drugs Compounded Semaglutide - Medical Weight
Description
The Employee Relations Dilemma: Coverage as Competitive Benefit or Budget Buster For many employers, the GLP-1 decision is less about clinical evidence or ROI projections and more about employee expectations and competitive positioning
Think of it as a pharmacological handoff rather than an abrupt swap
Leiter LA, Bain SC, Hramiak I, Jdar E, Madsbad S, Gondolf T, et al
GLP-1 medications naturally reduce hunger and thirst signals, so patients may forget to drink enough water throughout the day
Additional generics for Saxenda may enter the market on or after Feb
FDA Drug Approvals (2023) 10
